Cargando…
Data on the effect of hypomyelinating leukodystrophy 6 (HLD6)-associated mutations on the TUBB4A properties
Hypomyelinating leukodystrophy (HLD) is genetic demyelinating or dysmyelinating disease and is associated with at least 13 responsible genes. The mutations seem likely cause the functional deficiency of their gene products. HLD4- and HLD5-associated HSPD1 and FAM126A mutations affect biochemical pro...
Autores principales: | Miyamoto, Yuki, Torii, Tomohiro, Kawahara, Kazuko, Hasegawa, Nanami, Tanoue, Akito, Seki, Yoichi, Morimoto, Takako, Funakoshi-Tago, Megumi, Tamura, Hiroomi, Homma, Keiichi, Yamamoto, Masahiro, Yamauchi, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328720/ https://www.ncbi.nlm.nih.gov/pubmed/28275661 http://dx.doi.org/10.1016/j.dib.2017.02.024 |
Ejemplares similares
-
Defective oligodendrocyte differentiation by hypomyelinating leukodystrophy 13 (HLD13)-associated mutation of Hikeshi
por: Miyamoto, Yuki, et al.
Publicado: (2023) -
Defective myelination in mice harboring hypomyelinating leukodystrophy-associated HSPD1 mutation
por: Miyamoto, Yuki, et al.
Publicado: (2017) -
Hypomyelinating Leukodystrophy 10 (HLD10)-Associated Mutations of PYCR2 Form Large Size Mitochondria, Inhibiting Oligodendroglial Cell Morphological Differentiation
por: Torii, Tomohiro, et al.
Publicado: (2022) -
Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen
por: Sawaguchi, Sui, et al.
Publicado: (2021) -
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
por: Torii, Tomohiro, et al.
Publicado: (2023)